1204 In-situ reprograming of cancer cells to cDC1s elicits complete tumor regression and immune memory as monotherapy

• Xiaoli Huang,
• Fábio Rosa,
• Olga Zimmermannova,
• Cristiana Pires,
• Carlos-Filipe Pereira,
• Ervin Ascic,
• Fritiof Åkerström,
• André Rosa,
• Malavika Nair,
• Emilie Renaud

Affiliations

Xiaoli Huang

2Asgard Therapeutics AB, Lund, Sweden

Fábio Rosa

3Asgard Therapeutics, Lund, Sweden

Olga Zimmermannova

2Molecular Medicine and Gene Therapy, Lund, Sweden

Cristiana Pires

2Asgard Therapeutics AB, Lund, Sweden

Carlos-Filipe Pereira

3Asgard Therapeutics, Lund, Sweden

Ervin Ascic

1Lund University, Lund, Sweden

Fritiof Åkerström

2Asgard Therapeutics AB, Lund, Sweden

André Rosa

2Asgard Therapeutics AB, Lund, Sweden

Malavika Nair

1Lund University, Lund, Sweden

Emilie Renaud

2Asgard Therapeutics AB, Lund, Sweden